News

Home / News

TSH Biopharm Co., Ltd. signed an exclusive regional market and joint development agreement for osteoporosis biosimilar drugs.

2021.2.4

TSH biopharm Co., Ltd. (8432) announced today (2/4) that it has recently obtained an exclusive osteoporosis biosimilar drug (code name: TRIAS) in a specific regional market and joint development agreement with an international pharmaceutical company... View more